{
    "Trade/Device Name(s)": [
        "Advin Multi-Drug Screen Test Cassette",
        "Advin Multi-Drug Screen Test Dipcard",
        "Advin Multi-Drug Screen Test Cup"
    ],
    "Submitter Information": "Advin Biotech",
    "510(k) Number": "K122809",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061718"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DJC",
        "DIS",
        "JXM",
        "DJG",
        "LDJ",
        "DIO",
        "DJR",
        "LFG",
        "JXN",
        "LCM"
    ],
    "Summary Letter Date": "June 03, 2013",
    "Summary Letter Received Date": "June 06, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturates",
        "Benzodiazepines",
        "Buprenorphine",
        "Cocaine",
        "EDDP",
        "Ecstasy (MDMA)",
        "Methamphetamine",
        "Methadone",
        "Morphine",
        "Opiates",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Tricyclic-antidepressant",
        "Marijuana (THC)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Competitive binding assay"
    ],
    "Methodologies": [
        "Visual qualitative screening",
        "Membrane Particle Assay",
        "Antigen/Antibody Immunoassay"
    ],
    "Submission Type(s)": [
        "Cassette",
        "Dipcard",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Advin Multi-Drug Screen Test in Cassette, Dipcard, and Cup formats for qualitative detection of multiple drugs of abuse in human urine via immunochromatographic lateral flow assay",
    "Indications for Use Summary": "One-step immunoassay for the qualitative detection of multiple drugs of abuse and/or their metabolites in human urine for prescription, point-of-care, laboratory, workplace, and over-the-counter use (Propoxyphene test strip not for OTC use)",
    "fda_folder": "Toxicology"
}